About Event

The 3rd Next Generation Lipid-Based Nanoparticles Delivery Summit – What’s It About?

As we return for our third year, the 3rd Next Generation Lipid-Based Nanoparticle Delivery Summit stands as the premier event solely dedicated to the dynamic field of lipid-based nanoparticle delivery and its multifaceted challenges. With a strong emphasis on extrahepatic delivery, revolutionary novel payloads, and lipid-based therapies extending beyond LNPs, this year's summit promises to redefine the landscape of delivery innovation.

Explore discussions on device formulation and integration while tackling crucial nonclinical challenges like mitigating off-target effects and overcoming translatability hurdles.

Join Your Peers to:


Delve into the realm of precision targeting within LNP delivery, exploring the innovative strategies employed by industry leaders such as Teressa, Sanofi, and MediciBio.


Gain insights into this year's new content, focusing on the development of tailored delivery systems aimed at minimizing off-target effects while maximizing therapeutic impact through precise localization with Saliogen Therapeutics and Concardo.


Embark on a journey through the cutting-edge landscape of advanced LNP technologies, designed to confidently navigate the complexities of extra-hepatic delivery. Discover the latest breakthroughs from esteemed institutions like UC Berkeley, CureVac, and Kernal Therapeutics.


Explore the potential of next-generation payloads engineered for superior therapeutic efficacy, and learn about innovative solutions addressing key challenges in LNP delivery, such as payload stability and targeted release, paving the way for optimized therapeutic outcomes with Sanofi and Tessera.

Who Will You Meet?

LNP Summit
LNP Summit-297 resize


With 120+ industry peers who share your passion for drug delivery and are eager to explore cutting-edge advancements in next-generation lipid-based nanoparticle delivery.

Photos from the previous year's conference. To find out more about what is in store for 2024, take a look at our exciting brand-new agenda here.

What's New?

Tailoring delivery between local and systemic routes for precise targeting and enhanced therapeutic outcomes. Stay updated on device-formulation compatibility for innovative routes of administration, enabling tailored delivery to your target of interest and harmonizing in vivo and in vitro data.

LNP Summit-224 poster 4
LNP Summit-443 resize

What Your Peers Have to Say:

"I am looking forward to connecting with industry peers in the field of drug delivery. At the same time learn, share knowledge and understand the realm of nanoparticle technology"

Associate Director, Sanofi

"• Collaborating with those intrigued by cutting-edge technologies in next-generation LNP, especially muscle-selective gene delivery to minimize side effects of mRNA vaccines for infectious diseases and cancer, is something we are looking forward to."

Chief Executive Officer, MediciBio